[1]
M. I. Nandennavar, S. V. Karpurmath, G. Mandakalatur, and A. E. Prasad, “Clinical profile of hepatocellular carcinoma and experience with sorafenib from a tertiary cancer centre in Southern India”, Int J Res Med Sci, vol. 5, no. 2, pp. 379–383, Jan. 2017.